# Virocell Biologics Ltd — Form D

Virocell Biologics Ltd of LONDON, X0, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-15. The offering totals $2.3M, of which $993K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-11-15
- Form: D
- Accession: 0001878646-22-000052
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.3M
- Amount sold: $993K
- Remaining: $1.3M
- Investors: 4
- Date of first sale: 2022-11-01
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-464890

## Issuer

- Name: Virocell Biologics Ltd
- CIK: 0001948363
- Entity type: Corporation
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2020
- Address: Vestry House, LONDON, X0, EC4 OEH
- Phone: 442045585438

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Todd Christopher Davis | Director | Jupiter, FL |
| J David Enloe Jr. | Director | San Diego, CA |
| Farzin Eric Farzaneh | Director | London, X0 |
| John Winthrop Hadden II | Director | New York, NY |
| Peter Eric Priestley | Director | Dublin, L2 |
| Farzin Eric Farzaneh | Executive Officer | London, X0 |
| John Winthrop Hadden II | Executive Officer | New York, NY |

## More

- [CIK 1948363 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1948363&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001878646-22-000052.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.